Biofrontera outlines 80%-85% gross margin target for 2026 following strategic asset acquisition
Source: SeekingAlpha
2026-03-19 15:12:51 ET
More on Biofrontera
- Biofrontera sees Q4 2025 net sales of about $17M to $17.5M
- Seeking Alpha’s Quant Rating on Biofrontera
- Historical earnings data for Biofrontera
- Financial information for Biofrontera
Read the full article on Seeking Alpha
For further details see:
Biofrontera outlines 80%-85% gross margin target for 2026 following strategic asset acquisition
Biofrontera Inc.
NASDAQ: BFRI
BFRI Trading
-1.16% G/L:
$0.9646 Last:
98,508 Volume:
$0.99 Open:
BFRI Latest News
May 21, 2026 09:15:00 am
Biofrontera Inc. to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
May 14, 2026 07:30:00 am
Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update
May 13, 2026 09:00:00 am
Biofrontera Launches Second Annual "Hats On" Campaign to Raise Awareness of Actinic Keratosis
BFRI Stock Data
$9,085,692
7,913,871
2.28%
16
N/A
Pharmaceuticals
Healthcare
US
Woburn
